| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.92e-13 | 114 | 225 | 16 | GO:0004843 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 CAPN8 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 CAPN11 CAPN7 USP17L22 USP17L15 | 6.38e-13 | 192 | 225 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 7.33e-13 | 124 | 225 | 16 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 3.51e-12 | 137 | 225 | 16 | GO:0019783 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 USP17L1 USP17L20 PSMB8 USP17L19 USP17L18 CAPN8 USP17L17 ERAP2 ADAMTS16 USP17L3 MYRF CLCA4 DPP10 USP17L12 USP28 USP17L11 USP17L24 USP24 TASP1 USP17L5 USP17L10 CARD8 CAPN11 CAPN7 USP17L22 USP17L15 | 6.32e-09 | 654 | 225 | 27 | GO:0008233 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYCBP2 TBC1D3I TBC1D3G RASAL2 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ITSN1 SH2D3C ARHGAP9 TBC1D3C TBC1D3B MADD TBC1D8 ARHGAP12 AKAP13 ACAP2 CYTH4 | 7.41e-08 | 507 | 225 | 22 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYCBP2 TBC1D3I TBC1D3G RASAL2 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ITSN1 SH2D3C ARHGAP9 TBC1D3C TBC1D3B MADD TBC1D8 ARHGAP12 AKAP13 ACAP2 CYTH4 | 7.41e-08 | 507 | 225 | 22 | GO:0030695 |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3I TBC1D3G RASAL2 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP9 TBC1D3C TBC1D3B TBC1D8 ARHGAP12 ACAP2 | 1.20e-07 | 279 | 225 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.38e-05 | 28 | 225 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.39e-05 | 5 | 225 | 3 | GO:0140444 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.24e-05 | 18 | 225 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.64e-05 | 37 | 225 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | enzyme activator activity | PIK3CA TBC1D3I TBC1D3G RASAL2 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ITSN1 ARHGAP9 TBC1D3C TBC1D3B CARD8 MADD TBC1D8 ARHGAP12 ACAP2 | 5.68e-05 | 656 | 225 | 20 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | MYCBP2 ADGRV1 PIK3CA C3 PARP9 TBC1D3I TBC1D3G RASAL2 TBC1D3K TBC1D3F TBC1D3E TBC1D3 DEPTOR TBC1D3H TBC1D3L TBC1D3D UGT1A7 ITSN1 SH2D3C ARHGAP9 TBC1D3C TBC1D3B PABIR3 CARD8 MADD TBC1D8 CCNF FRY ARHGAP12 AKAP13 ACAP2 CYTH4 | 1.32e-04 | 1418 | 225 | 32 | GO:0030234 |
| GeneOntologyMolecularFunction | molecular adaptor activity | WWOX HNRNPU MED24 TDRD3 STXBP1 ANAPC1 SYNE2 AP1G2 AP1M1 PARP9 CAMTA1 HOMER1 BICD2 ANK1 SYNE1 ITSN1 SUN1 SH2D3C CGAS TRIM31 AP1M2 SH2B2 CARD8 SRRT PDLIM1 MYH14 SMARCA2 AKAP13 KLHDC10 | 6.67e-04 | 1356 | 225 | 29 | GO:0060090 |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 8.54e-04 | 17 | 225 | 3 | GO:0004198 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.16e-03 | 70 | 225 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | lamin binding | 1.20e-03 | 19 | 225 | 3 | GO:0005521 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | WWOX HNRNPU MED24 TDRD3 SYNE2 AP1G2 AP1M1 PARP9 CAMTA1 HOMER1 BICD2 ANK1 SYNE1 SUN1 SH2D3C CGAS TRIM31 AP1M2 SH2B2 CARD8 SRRT PDLIM1 SMARCA2 AKAP13 KLHDC10 | 1.43e-03 | 1160 | 225 | 25 | GO:0030674 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 5.13e-13 | 125 | 225 | 16 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 4.72e-12 | 144 | 225 | 16 | GO:0070646 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D8 | 2.62e-09 | 109 | 225 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | microtubule-based transport | ADCY10 IFT172 HNRNPU DST SYNE2 CFAP45 TTLL1 BICD2 SUN1 CCDC39 MADD KIF13A DNAH11 | 4.47e-06 | 253 | 225 | 13 | GO:0099111 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRPM4 USP17L21 USP17L1 MYCBP2 USP17L20 USP17L19 USP17L18 MED24 USP17L17 UBR5 ANAPC1 USP17L3 TRAF7 SLF1 USP17L12 USP28 USP17L11 USP17L24 USP24 TRIM31 USP17L5 RNF213 USP17L10 CCNF UBE2O KLHDC10 USP17L22 USP17L15 | 5.59e-06 | 1009 | 225 | 28 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRPM4 USP17L21 USP17L1 MYCBP2 USP17L20 USP17L19 USP17L18 MED24 USP17L17 UBR5 ANAPC1 USP17L3 PARP9 TRAF7 SLF1 USP17L12 USP28 USP17L11 USP17L24 USP24 TRIM31 USP17L5 RNF213 USP17L10 CCNF UBE2O KLHDC10 USP17L22 USP17L15 | 6.34e-06 | 1074 | 225 | 29 | GO:0043687 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 IFT172 HNRNPU DNAAF5 DST SYNE2 CFAP45 TTLL1 BICD2 SUN1 DNAH2 DNAH7 CCDC39 MADD DNAH17 TEKT4 KIF13A DNAH11 | 8.49e-06 | 493 | 225 | 18 | GO:0007018 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D8 | 1.62e-05 | 244 | 225 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | self proteolysis | 1.71e-05 | 15 | 225 | 4 | GO:0097264 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP9 TBC1D3C TBC1D3B TBC1D8 ARHGAP12 | 2.02e-05 | 335 | 225 | 14 | GO:0043087 |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 2.94e-05 | 17 | 225 | 4 | GO:0036159 | |
| GeneOntologyBiologicalProcess | cilium assembly | IFT172 KIAA0753 CEP350 DNAAF5 SYNE2 ADAMTS16 TTLL1 TBC1D3 SYNE1 FBF1 DNAH2 DNAH7 CCDC39 TBC1D8 DNAH17 TEKT4 | 3.19e-05 | 444 | 225 | 16 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 IFT172 PEX13 CEP76 HNRNPU KIAA0753 CEP350 DNAAF5 DST SYNE2 CFAP45 TTLL1 TBCE BICD2 SUN1 DNAH2 DNAH7 CCDC39 MADD CCNF DNAH17 NINL MACF1 TEKT4 KIF13A NUDC DNAH11 | 3.65e-05 | 1058 | 225 | 27 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium organization | IFT172 KIAA0753 CEP350 DNAAF5 SYNE2 ADAMTS16 TTLL1 TBC1D3 SYNE1 FBF1 DNAH2 DNAH7 CCDC39 TBC1D8 DNAH17 TEKT4 | 7.27e-05 | 476 | 225 | 16 | GO:0044782 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 8.04e-05 | 41 | 225 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | nucleus localization | 1.13e-04 | 44 | 225 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | organelle assembly | SNF8 IFT172 SPTBN2 CEP76 HNRNPU KIAA0753 CEP350 DNAAF5 NLGN3 MDN1 SYNE2 ADAMTS16 AP1M1 TTLL1 TRAF7 TBC1D3 SYNE1 FBF1 DNAH2 RNF213 DNAH7 CCDC39 TBC1D8 DNAH17 AKAP13 TEKT4 PRKDC | 1.24e-04 | 1138 | 225 | 27 | GO:0070925 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.64e-06 | 9 | 227 | 4 | GO:0014731 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 USP17L1 USP17L20 MR1 USP17L19 NCLN PTGFRN LRIT3 RYR1 USP17L18 DST USP17L17 ERAP2 SYNE2 OSBPL5 USP17L3 MYRF NOS1 BICD2 USP17L12 USP17L11 SYNE1 UGT1A7 TUSC3 USP17L5 USP17L10 OCA2 GRIN2C POMT1 LRRC8D ABCC12 USP17L22 USP17L15 | 7.19e-06 | 1327 | 227 | 33 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 USP17L1 USP17L20 MR1 USP17L19 NCLN PTGFRN LRIT3 RYR1 USP17L18 DST USP17L17 ERAP2 SYNE2 OSBPL5 USP17L3 MYRF NOS1 USP17L12 USP17L11 UGT1A7 TUSC3 USP17L5 USP17L10 OCA2 GRIN2C POMT1 LRRC8D ABCC12 USP17L22 USP17L15 | 2.84e-05 | 1293 | 227 | 31 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 USP17L1 USP17L20 MR1 USP17L19 NCLN PTGFRN LRIT3 RYR1 USP17L18 DST USP17L17 ERAP2 SYNE2 OSBPL5 USP17L3 MYRF NOS1 USP17L12 USP17L11 UGT1A7 TUSC3 USP17L5 USP17L10 OCA2 GRIN2C POMT1 LRRC8D ABCC12 USP17L22 USP17L15 | 3.11e-05 | 1299 | 227 | 31 | GO:0098827 |
| GeneOntologyCellularComponent | spectrin | 1.01e-04 | 9 | 227 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.96e-04 | 11 | 227 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.96e-04 | 11 | 227 | 3 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.96e-04 | 11 | 227 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.96e-04 | 11 | 227 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | supramolecular fiber | RYR1 HNRNPU DST SYNJ2 SYNE2 CFAP45 TTLL1 DMD NOS1 HOMER1 TBCE ANK1 SYNE1 FBF1 DNAH2 SH2B2 DNAH7 PDLIM1 MYH14 DNAH17 NINL MACF1 AKAP13 TEKT4 KIF13A NUDC DNAH11 | 2.06e-04 | 1179 | 227 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | RYR1 HNRNPU DST SYNJ2 SYNE2 CFAP45 TTLL1 DMD NOS1 HOMER1 TBCE ANK1 SYNE1 FBF1 DNAH2 SH2B2 DNAH7 PDLIM1 MYH14 DNAH17 NINL MACF1 AKAP13 TEKT4 KIF13A NUDC DNAH11 | 2.29e-04 | 1187 | 227 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | Z disc | 2.51e-04 | 151 | 227 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | AP-1 adaptor complex | 2.59e-04 | 12 | 227 | 3 | GO:0030121 | |
| GeneOntologyCellularComponent | I band | 4.74e-04 | 166 | 227 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | cytoplasmic region | IFT172 HNRNPU DST STXBP1 CFAP45 DNAH2 DNAH7 CCDC39 MADD DNAH17 TEKT4 DNAH11 | 6.03e-04 | 360 | 227 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | IFT172 HNRNPU DST CFAP45 DNAH2 DNAH7 CCDC39 MADD DNAH17 TEKT4 DNAH11 | 7.30e-04 | 317 | 227 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | microtubule | HNRNPU DST SYNJ2 CFAP45 TTLL1 TBCE DNAH2 DNAH7 DNAH17 NINL MACF1 TEKT4 KIF13A NUDC DNAH11 | 7.63e-04 | 533 | 227 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | clathrin coat of trans-Golgi network vesicle | 9.14e-04 | 18 | 227 | 3 | GO:0030130 | |
| GeneOntologyCellularComponent | cell leading edge | ADGRV1 FAT1 DST SYNJ2 PIK3CA SYNE2 DMD CDC42BPG ANK1 ITSN1 SH2D3C SH2B2 MACF1 ACAP2 | 1.19e-03 | 500 | 227 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SNF8 ADCY10 SPTBN2 ADGRV1 RYR1 FAT1 DST STXBP1 UBR5 SYNJ2 PIK3CA DMD NOS1 TRAF7 SYNE1 PRDX6 CASK CCNF AKAP13 CDC5L GALNT4 | 1.34e-03 | 934 | 227 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | sarcomere | 1.66e-03 | 249 | 227 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 1.67e-03 | 22 | 227 | 3 | GO:0012510 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.71e-03 | 6 | 227 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | motile cilium | ADCY10 IFT172 DNAAF5 CFAP45 TTLL1 DNAH2 DNAH7 CCDC39 DNAH17 TEKT4 DNAH11 | 1.81e-03 | 355 | 227 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | axoneme | 1.97e-03 | 207 | 227 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | HNRNPU DST SYNJ2 CFAP45 TTLL1 DMD TBCE FBF1 DNAH2 SH2B2 DNAH7 PDLIM1 DNAH17 NINL MACF1 AKAP13 TEKT4 KIF13A NUDC DNAH11 | 1.97e-03 | 899 | 227 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | ciliary plasm | 2.03e-03 | 208 | 227 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.44e-03 | 25 | 227 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.73e-03 | 88 | 227 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | dynein complex | 2.80e-03 | 54 | 227 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | myofibril | 3.08e-03 | 273 | 227 | 9 | GO:0030016 | |
| MousePheno | abnormal cellular hemoglobin content | 8.20e-06 | 12 | 163 | 4 | MP:0008954 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.06e-18 | 16 | 221 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.06e-18 | 16 | 221 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 1.22e-15 | 66 | 221 | 15 | IPR018200 |
| Domain | UCH | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 3.94e-15 | 71 | 221 | 15 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 3.94e-15 | 71 | 221 | 15 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 4.93e-15 | 72 | 221 | 15 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 4.93e-15 | 72 | 221 | 15 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 4.93e-15 | 72 | 221 | 15 | IPR001394 |
| Domain | USP_1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 | 7.51e-14 | 70 | 221 | 14 | PS00972 |
| Domain | TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D8 | 9.75e-12 | 49 | 221 | 11 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D8 | 2.45e-11 | 53 | 221 | 11 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D8 | 3.76e-11 | 55 | 221 | 11 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D8 | 3.76e-11 | 55 | 221 | 11 | PS50086 |
| Domain | Spectrin | 1.42e-10 | 23 | 221 | 8 | PF00435 | |
| Domain | Spectrin_repeat | 1.17e-09 | 29 | 221 | 8 | IPR002017 | |
| Domain | SPEC | 2.79e-09 | 32 | 221 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.79e-09 | 32 | 221 | 8 | IPR018159 | |
| Domain | ACTININ_2 | 6.16e-09 | 23 | 221 | 7 | PS00020 | |
| Domain | ACTININ_1 | 6.16e-09 | 23 | 221 | 7 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.16e-09 | 23 | 221 | 7 | IPR001589 | |
| Domain | IRO | 2.81e-07 | 6 | 221 | 4 | SM00548 | |
| Domain | Iroquois_homeo | 2.81e-07 | 6 | 221 | 4 | IPR003893 | |
| Domain | CH | 1.15e-05 | 65 | 221 | 7 | SM00033 | |
| Domain | CH | 1.88e-05 | 70 | 221 | 7 | PF00307 | |
| Domain | - | 2.07e-05 | 71 | 221 | 7 | 1.10.418.10 | |
| Domain | CH | 2.48e-05 | 73 | 221 | 7 | PS50021 | |
| Domain | CH-domain | 2.96e-05 | 75 | 221 | 7 | IPR001715 | |
| Domain | Homeobox_KN | 4.02e-05 | 17 | 221 | 4 | PF05920 | |
| Domain | Homeobox_KN_domain | 4.02e-05 | 17 | 221 | 4 | IPR008422 | |
| Domain | - | 1.18e-04 | 22 | 221 | 4 | 2.130.10.30 | |
| Domain | PH | SPTBN2 OSBPL5 RASAL2 TECPR1 CDC42BPG ITSN1 ARHGAP9 SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 1.24e-04 | 278 | 221 | 12 | SM00233 |
| Domain | PH_DOMAIN | SPTBN2 OSBPL5 RASAL2 TECPR1 CDC42BPG ITSN1 ARHGAP9 SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 1.28e-04 | 279 | 221 | 12 | PS50003 |
| Domain | PH_domain | SPTBN2 OSBPL5 RASAL2 TECPR1 CDC42BPG ITSN1 ARHGAP9 SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 1.33e-04 | 280 | 221 | 12 | IPR001849 |
| Domain | RCC1/BLIP-II | 1.42e-04 | 23 | 221 | 4 | IPR009091 | |
| Domain | PH_dom-like | SPTBN2 OSBPL5 PARP9 HOMER1 RASAL2 TECPR1 CDC42BPG ITSN1 ARHGAP9 NBEA SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 1.77e-04 | 426 | 221 | 15 | IPR011993 |
| Domain | - | SPTA1 RYR1 CAPN8 DST DMD SLC25A24 ITSN1 CAPN11 TBC1D8 NINL MACF1 | 2.91e-04 | 261 | 221 | 11 | 1.10.238.10 |
| Domain | calpain_III | 3.32e-04 | 12 | 221 | 3 | SM00720 | |
| Domain | C2_III | 3.32e-04 | 12 | 221 | 3 | IPR033883 | |
| Domain | Calpain_III | 3.32e-04 | 12 | 221 | 3 | IPR022683 | |
| Domain | PH | SPTBN2 OSBPL5 CDC42BPG ITSN1 ARHGAP9 SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 4.14e-04 | 229 | 221 | 10 | PF00169 |
| Domain | Calpain_III | 4.28e-04 | 13 | 221 | 3 | PF01067 | |
| Domain | Calpain_domain_III | 4.28e-04 | 13 | 221 | 3 | IPR022682 | |
| Domain | EF_hand_dom | 4.59e-04 | 232 | 221 | 10 | IPR002048 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.40e-04 | 14 | 221 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.40e-04 | 14 | 221 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.40e-04 | 14 | 221 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.40e-04 | 14 | 221 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.40e-04 | 14 | 221 | 3 | IPR011704 | |
| Domain | Calpain_cysteine_protease | 5.40e-04 | 14 | 221 | 3 | IPR022684 | |
| Domain | MT | 5.40e-04 | 14 | 221 | 3 | PF12777 | |
| Domain | AAA_8 | 5.40e-04 | 14 | 221 | 3 | PF12780 | |
| Domain | AAA_5 | 5.40e-04 | 14 | 221 | 3 | PF07728 | |
| Domain | EFh | 5.97e-04 | 158 | 221 | 8 | SM00054 | |
| Domain | EF-hand-dom_pair | SPTA1 RYR1 CAPN8 DST DMD SLC25A24 ITSN1 CAPN11 TBC1D8 NINL MACF1 | 6.46e-04 | 287 | 221 | 11 | IPR011992 |
| Domain | DHC_fam | 6.69e-04 | 15 | 221 | 3 | IPR026983 | |
| Domain | Peptidase_C2 | 6.69e-04 | 15 | 221 | 3 | PF00648 | |
| Domain | Dynein_heavy | 6.69e-04 | 15 | 221 | 3 | PF03028 | |
| Domain | CysPc | 6.69e-04 | 15 | 221 | 3 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 6.69e-04 | 15 | 221 | 3 | IPR001300 | |
| Domain | Dynein_heavy_dom | 6.69e-04 | 15 | 221 | 3 | IPR004273 | |
| Domain | CALPAIN_CAT | 6.69e-04 | 15 | 221 | 3 | PS50203 | |
| Domain | - | SPTBN2 OSBPL5 HOMER1 RASAL2 TECPR1 CDC42BPG ITSN1 ARHGAP9 SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 8.11e-04 | 391 | 221 | 13 | 2.30.29.30 |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | IPR012315 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | PS51049 | |
| Domain | LRRC37AB_C | 8.23e-04 | 4 | 221 | 2 | IPR029423 | |
| Domain | Spectrin_bsu | 8.23e-04 | 4 | 221 | 2 | IPR016343 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | SM01249 | |
| Domain | LRRC37AB_C | 8.23e-04 | 4 | 221 | 2 | PF14914 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | PF10541 | |
| Domain | LRRC37_N | 8.23e-04 | 4 | 221 | 2 | IPR032754 | |
| Domain | LRRC37 | 8.23e-04 | 4 | 221 | 2 | PF15779 | |
| Domain | LRRC37A/B-like | 8.23e-04 | 4 | 221 | 2 | IPR015753 | |
| Domain | Rho_GTPase_act | 8.23e-04 | 4 | 221 | 2 | IPR015767 | |
| Domain | EF_Hand_1_Ca_BS | 1.16e-03 | 175 | 221 | 8 | IPR018247 | |
| Domain | AAA | 1.65e-03 | 144 | 221 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.65e-03 | 144 | 221 | 7 | IPR003593 | |
| Domain | - | 2.03e-03 | 6 | 221 | 2 | 3.90.1290.10 | |
| Domain | Clathrin_mu_CS | 2.03e-03 | 6 | 221 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 2.03e-03 | 6 | 221 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 2.03e-03 | 6 | 221 | 2 | PS00991 | |
| Domain | GAR | 2.03e-03 | 6 | 221 | 2 | PS51460 | |
| Domain | GAS2 | 2.03e-03 | 6 | 221 | 2 | PF02187 | |
| Domain | - | 2.03e-03 | 6 | 221 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 2.03e-03 | 6 | 221 | 2 | IPR003108 | |
| Domain | GAS2 | 2.03e-03 | 6 | 221 | 2 | SM00243 | |
| Domain | Plectin | 2.81e-03 | 7 | 221 | 2 | PF00681 | |
| Domain | Plectin_repeat | 2.81e-03 | 7 | 221 | 2 | IPR001101 | |
| Domain | PLEC | 2.81e-03 | 7 | 221 | 2 | SM00250 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.36e-15 | 45 | 177 | 13 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 PSMB8 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.25e-09 | 191 | 177 | 16 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 PSMB8 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.57e-09 | 221 | 177 | 17 | M27578 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L1 USP17L20 SPTA1 SPTB SPTBN2 PSMB8 USP17L19 USP17L18 USP17L17 PIK3CA USP17L3 RASAL2 VWF USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 3.20e-09 | 318 | 177 | 20 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 PSMB8 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.96e-07 | 262 | 177 | 16 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 PSMB8 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.22e-07 | 299 | 177 | 17 | M27574 |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B | 4.15e-06 | 99 | 177 | 9 | M46448 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.76e-06 | 10 | 177 | 4 | MM15112 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 6.95e-05 | 56 | 177 | 6 | M27616 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | GALNT15 USP17L21 USP17L1 NANP USP17L20 SPTA1 SPTB SPTBN2 PSMB8 PEX13 USP17L19 USP17L18 USP17L17 ADAMTS16 USP17L3 C3 TTLL1 ANK1 USP17L12 USP28 USP17L11 TUSC3 USP17L24 USP24 NUP88 USP17L5 USP17L10 POMT1 CCNF A4GNT ZNF350 PRKDC USP17L22 USP17L15 GALNT4 | 1.54e-04 | 1475 | 177 | 35 | M19806 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 7.92e-25 | 11 | 229 | 11 | 16863688 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.02e-24 | 21 | 229 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.02e-24 | 21 | 229 | 13 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.02e-24 | 21 | 229 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.02e-24 | 21 | 229 | 13 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.02e-24 | 21 | 229 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 6.02e-24 | 21 | 229 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 1.46e-23 | 22 | 229 | 13 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 7.26e-23 | 24 | 229 | 13 | 8995226 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.41e-22 | 33 | 229 | 14 | 20228807 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 1.50e-22 | 25 | 229 | 13 | 21115691 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 17109758 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 20368735 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.39e-22 | 34 | 229 | 14 | 21448158 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 2.99e-22 | 26 | 229 | 13 | 35816173 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 3.95e-22 | 35 | 229 | 14 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 3.95e-22 | 35 | 229 | 14 | 21239494 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 6.43e-22 | 36 | 229 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.03e-21 | 37 | 229 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 1.92e-21 | 29 | 229 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 8.87e-18 | 50 | 229 | 13 | 31806660 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 SPTBN2 OIP5 RYR1 HNRNPU TDRD3 DST MDN1 USP17L3 NCR1 CDC42BPG ANK1 USP17L12 ITSN1 DNAH2 RNF213 ARHGAP9 NBEA CCDC39 FRY PDLIM1 AKAP13 PRKDC RBM41 | 1.54e-10 | 736 | 229 | 24 | 29676528 |
| Pubmed | ILF3 MYCBP2 SPTBN2 HNRNPU NLGN3 TDRD3 FARSA DST MDN1 UBR5 ANAPC1 SYNE2 NOS1 KCNT1 HOMER1 RASAL2 DMXL2 USP28 SYNE1 ITSN1 DPYSL4 NBEA CASK FRY UBE2O MACF1 CDC5L | 2.93e-10 | 963 | 229 | 27 | 28671696 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | LRRC37A2 TBC1D3G TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3D RNF213 TBC1D3B | 1.51e-09 | 74 | 229 | 9 | 16625196 |
| Pubmed | EPRS1 ILF3 SPTA1 SPTB SPTBN2 HNRNPU NLGN3 FARSA DST STXBP1 DMD NOS1 HOMER1 RASAL2 CKMT1A DMXL2 VWF OXR1 SYNE1 ITSN1 DPYSL4 NBEA OGDH PRDX6 MADD CASK SRRT UBE2O MYH14 MACF1 CDC5L DNAH11 | 1.65e-09 | 1431 | 229 | 32 | 37142655 | |
| Pubmed | 5.30e-09 | 11 | 229 | 5 | 10926765 | ||
| Pubmed | Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos. | 2.72e-08 | 6 | 229 | 4 | 20408909 | |
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 11042145 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 36773339 | ||
| Pubmed | Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. | 2.72e-08 | 6 | 229 | 4 | 10370142 | |
| Pubmed | EPRS1 MYCBP2 IFT172 SPTB SPTBN2 CEP350 WDR3 DST STXBP1 RASAL2 BICD2 DMXL2 VWF OXR1 USP28 SYNE1 ITSN1 NBEA MADD CASK FRY UBE2O GTF3A MYH14 RCBTB1 MACF1 ZNF350 PRKDC | 3.28e-08 | 1285 | 229 | 28 | 35914814 | |
| Pubmed | The prepattern transcription factor Irx3 directs nephron segment identity. | 6.31e-08 | 7 | 229 | 4 | 17875669 | |
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 11118473 | ||
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 NLGN3 CLCN5 USP17L17 NYNRIN CFAP45 USP17L3 ANK1 USP17L12 USP17L11 USP17L5 USP17L10 IRAK3 USP17L22 USP17L15 | 1.34e-07 | 674 | 229 | 19 | 37196079 | |
| Pubmed | 1.69e-07 | 20 | 229 | 5 | 21689717 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DCAKD TRPM4 WWOX MYCBP2 SPTB ADGRV1 HNRNPU DNAAF5 NLGN3 PTPRB SYNJ2 OSBPL5 CAMTA1 FAM149A CDC42BPG DEPTOR TUSC3 RNF213 POMT1 TEP1 OGDH LRRC8D PRDX6 CASK MYH14 SMARCA2 LRP5 MACF1 AKAP13 | 1.98e-07 | 1489 | 229 | 29 | 28611215 |
| Pubmed | 2.25e-07 | 9 | 229 | 4 | 14585979 | ||
| Pubmed | Gene and cluster-specific expression of the Iroquois family members during mouse development. | 2.25e-07 | 9 | 229 | 4 | 11520674 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.82e-07 | 3 | 229 | 3 | 16079285 | |
| Pubmed | Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells. | 2.82e-07 | 3 | 229 | 3 | 15929114 | |
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 1385865 | ||
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 6763106 | ||
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 35328612 | ||
| Pubmed | EPRS1 ILF3 SPTA1 SPTBN2 HNRNPU C4orf17 ACSM3 DST MDN1 STXBP1 CLCN5 SYNE2 CFAP45 TTLL1 DMD SYNE1 ITSN1 FBF1 DNAH2 OGDH CAPN11 MYH14 BAZ1A ARHGAP12 MACF1 IRAK3 ZNF350 PRKDC | 3.47e-07 | 1442 | 229 | 28 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 ILF3 MYCBP2 SPTBN2 NCLN HNRNPU CEP350 WDR3 DST MDN1 UBR5 SYNE2 SYNE1 SUN1 PRDX6 SRRT PDLIM1 MYH14 BAZ1A MACF1 PRKDC CDC5L NUDC | 3.57e-07 | 1024 | 229 | 23 | 24711643 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 PCNX3 MYCBP2 NCLN RYR1 TDRD3 FAT1 DST MDN1 OSBPL5 AP1G2 MYRF TRAF7 TASP1 LRRK1 TEP1 SH2B2 MADD TKFC NINL LRP5 AKAP13 PRKDC CYTH4 | 3.58e-07 | 1105 | 229 | 24 | 35748872 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 3.73e-07 | 10 | 229 | 4 | 22159418 | |
| Pubmed | 5.14e-07 | 187 | 229 | 10 | 26460568 | ||
| Pubmed | 7.28e-07 | 76 | 229 | 7 | 27542412 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 16648470 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 379653 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 33620149 | ||
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 1.12e-06 | 4 | 229 | 3 | 28716842 | |
| Pubmed | iNOS is not responsible for RyR1Â S-nitrosylation in mdx mice with truncated dystrophin. | 1.12e-06 | 4 | 229 | 3 | 32693782 | |
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 1.12e-06 | 4 | 229 | 3 | 23071752 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.12e-06 | 4 | 229 | 3 | 12359748 | |
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 6234993 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 21412925 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 10772878 | ||
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 1.12e-06 | 4 | 229 | 3 | 20108321 | |
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 8954775 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 8406013 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L20 USP17L19 USP17L18 DNAAF5 USP17L17 USP17L12 USP17L11 | 1.31e-06 | 119 | 229 | 8 | 28625976 |
| Pubmed | LRRC37A3 NCLN RYR1 CEP350 MDN1 STXBP1 SYNE2 RASAL2 FAM149A FBF1 USP24 DNAH2 NBEA DNAH7 SMARCA2 IRAK3 DNAH11 | 1.34e-06 | 638 | 229 | 17 | 31182584 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TRPM4 APTX PTGFRN PGGT1B F13A1 ACSM3 CLCN5 UBR5 SYNJ2 MYRF RASAL2 SYNE1 POMT1 MADD TBC1D8 MACF1 KIF13A ACAP2 | 1.58e-06 | 719 | 229 | 18 | 35337019 |
| Pubmed | 1.74e-06 | 14 | 229 | 4 | 9373155 | ||
| Pubmed | 2.74e-06 | 225 | 229 | 10 | 12168954 | ||
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 12604796 | ||
| Pubmed | Iroquois genes influence proximo-distal morphogenesis during rat lung development. | 2.79e-06 | 5 | 229 | 3 | 16299054 | |
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 2.79e-06 | 5 | 229 | 3 | 22632968 | |
| Pubmed | Expression of two novel mouse Iroquois homeobox genes during neurogenesis. | 2.79e-06 | 5 | 229 | 3 | 10704856 | |
| Pubmed | Major erythrocyte membrane protein genes in EKLF-deficient mice. | 2.79e-06 | 5 | 229 | 3 | 16728274 | |
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 8471161 | ||
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 18396275 | ||
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 11335133 | ||
| Pubmed | GALNT15 ADGRV1 NCLN C4orf17 TDRD3 SYNE2 OSBPL5 TTLL1 TBC1D3F SLC25A24 TRAF7 TBC1D3 SLF1 DEPTOR TBC1D3D SRRT RCBTB1 NUDC | 2.84e-06 | 750 | 229 | 18 | 11230166 | |
| Pubmed | DCAKD EPRS1 ILF3 MYCBP2 PEX13 NCLN HNRNPU CEP350 FARSA MDN1 CLCN5 UBR5 OSBPL5 AP1M1 PARP9 RNF213 LRRC8D PRDX6 MYH14 AKAP13 PRKDC CDC5L ACAP2 | 3.30e-06 | 1168 | 229 | 23 | 19946888 | |
| Pubmed | DST NYNRIN OSBPL5 ZNF282 TECPR1 SYNE1 DNAH2 DNAH7 KLHDC10 DNAH11 | 3.74e-06 | 233 | 229 | 10 | 37704626 | |
| Pubmed | SPTBN2 CEP350 DST SYNJ2 NFYC DMD TBC1D3F VWF SYNE1 ITSN1 MADD MACF1 AKAP13 PRKDC | 4.88e-06 | 486 | 229 | 14 | 20936779 | |
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 27848995 | ||
| Pubmed | SPTBN2 NLGN3 UBR5 HOMER1 RASAL2 DMXL2 SYNE1 NBEA UBE2O MACF1 | 7.21e-06 | 251 | 229 | 10 | 27507650 | |
| Pubmed | 9.67e-06 | 7 | 229 | 3 | 33139725 | ||
| Pubmed | 9.67e-06 | 7 | 229 | 3 | 31178125 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | SNF8 LRRC37A3 APTX SPTBN2 HNRNPU TDRD3 AP1G2 AP1M1 TBCE USP28 ITSN1 POMT1 PRDX6 MADD CASK BAZ1A KIF13A ACAP2 FILIP1L | 1.37e-05 | 925 | 229 | 19 | 28986522 |
| Pubmed | 1.54e-05 | 8 | 229 | 3 | 10822268 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.83e-05 | 170 | 229 | 8 | 23314748 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTBN2 NLGN3 STXBP1 UBR5 HOMER1 RASAL2 DMXL2 SYNE1 NBEA MACF1 | 1.92e-05 | 281 | 229 | 10 | 28706196 |
| Pubmed | EPRS1 ILF3 WWOX HNRNPU FARSA DST RASAL2 TBCE USP24 PRDX6 TBC1D8 PDLIM1 ARHGAP12 MACF1 PRKDC NUDC | 2.14e-05 | 708 | 229 | 16 | 39231216 | |
| Pubmed | MYCBP2 DST STXBP1 TMEM163 ADGRL3 DMXL2 OXR1 ITSN1 NBEA MADD MACF1 | 2.15e-05 | 347 | 229 | 11 | 17114649 | |
| Pubmed | EPRS1 ILF3 HNRNPU SLC25A24 PRDX6 SRRT MYH14 SMARCA2 PRKDC CDC5L | 2.23e-05 | 286 | 229 | 10 | 32041737 | |
| Pubmed | 2.30e-05 | 9 | 229 | 3 | 11222723 | ||
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 6.77e-15 | 79 | 229 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 2.82e-10 | 149 | 229 | 11 | chr17q12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.56e-09 | 222 | 229 | 12 | chr4p16 |
| Cytoband | 17q12 | 1.44e-04 | 99 | 229 | 5 | 17q12 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTB SPTBN2 OSBPL5 RASAL2 CDC42BPG ITSN1 ARHGAP9 SH2B2 ARHGAP12 AKAP13 ACAP2 CYTH4 | 4.34e-08 | 206 | 134 | 12 | 682 |
| GeneFamily | Dyneins, axonemal | 6.37e-06 | 17 | 134 | 4 | 536 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.36e-05 | 7 | 134 | 3 | 1113 | |
| GeneFamily | EF-hand domain containing | 3.75e-05 | 219 | 134 | 9 | 863 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 3.80e-05 | 26 | 134 | 4 | 526 | |
| GeneFamily | C2 domain containing|Calpains | 1.70e-04 | 15 | 134 | 3 | 975 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.24e-04 | 4 | 134 | 2 | 1252 | |
| GeneFamily | NudC family | 3.24e-04 | 4 | 134 | 2 | 1285 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.48e-03 | 8 | 134 | 2 | 939 | |
| GeneFamily | WD repeat domain containing | 3.42e-03 | 262 | 134 | 7 | 362 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 MED24 USP17L17 USP17L3 HOMER1 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 5.09e-14 | 112 | 226 | 15 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 5.14e-13 | 86 | 226 | 13 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 C3 USP17L12 USP17L11 USP17L5 USP17L10 USP17L22 USP17L15 | 1.27e-10 | 160 | 226 | 14 | MM1155 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYCBP2 CEP350 TDRD3 FAT1 DST MDN1 UBR5 SYNJ2 SYNE2 NFYC DMD HOMER1 SLC25A24 DMXL2 ITSN1 USP24 CASK BAZ1A ARHGAP12 SMARCA2 MACF1 AKAP13 KLHDC10 ACAP2 FILIP1L | 1.16e-07 | 856 | 226 | 25 | M4500 |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | EPRS1 ILF3 CCDC18 WDR3 HSF2 SUN1 TEP1 GTF3A SMARCA2 MACF1 PRKDC FILIP1L | 1.33e-07 | 194 | 226 | 12 | M8017 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | SNF8 USP17L21 USP17L1 USP17L20 USP17L19 ACOX2 USP17L18 USP17L17 USP17L3 TTLL1 USP17L12 USP17L11 SH2D3C USP17L5 USP17L10 TBC1D8 UBE2O TKFC PDLIM1 USP17L22 USP17L15 | 2.31e-07 | 647 | 226 | 21 | MM981 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | EPRS1 PSMB8 PEX13 CEP350 WDR3 TDRD3 MDN1 UBR5 ERAP2 PIK3CA SYNE2 NFYC HSF2 DMXL2 OXR1 SUN1 LRRC8D PRDX6 CARD8 GTF3A BAZ1A CAPN7 ARHGAP12 MACF1 ZFTA PRKDC KLHDC10 RBM41 | 2.28e-06 | 1215 | 226 | 28 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 CEP350 FAT1 DST MDN1 UBR5 NFYC HOMER1 ITSN1 USP24 CASK BAZ1A ARHGAP12 SMARCA2 FILIP1L | 1.43e-05 | 466 | 226 | 15 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 2.35e-05 | 176 | 226 | 9 | M39223 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | MYCBP2 SPTBN2 FNDC5 IRX4 PTPRB KCNT1 DOC2B DPP10 ANK1 COMP DPYSL4 GRIN2C IRX1 SYT10 | 2.99e-05 | 438 | 226 | 14 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | MYCBP2 SPTBN2 FNDC5 IRX4 PTPRB KCNT1 DOC2B DPP10 ANK1 COMP DPYSL4 GRIN2C IRX1 SYT10 | 3.14e-05 | 440 | 226 | 14 | MM832 |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 5.46e-05 | 152 | 226 | 8 | M2964 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP | 5.66e-05 | 197 | 226 | 9 | M8022 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L1 USP17L20 KDM5C CCDC18 USP17L19 HNRNPU USP17L18 USP17L17 SYNJ2 USP17L3 TBCE SLC25A24 USP17L12 USP17L11 CGAS USP17L5 USP17L10 LRRC8D PRDX6 ARHGAP12 USP17L22 USP17L15 | 5.84e-05 | 1072 | 226 | 23 | MM1031 |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_UP | 6.12e-05 | 199 | 226 | 9 | M4507 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 6.36e-05 | 200 | 226 | 9 | M331 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP | 6.36e-05 | 200 | 226 | 9 | M7411 | |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 9.71e-05 | 165 | 226 | 8 | M8992 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 3.04e-07 | 90 | 213 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | C3 TBC1D3G MYRF TBC1D3K TBC1D3F VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B NINL | 1.09e-06 | 242 | 213 | 13 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | C3 TBC1D3G MYRF TBC1D3K TBC1D3F VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.73e-06 | 213 | 213 | 12 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | C3 TBC1D3G MYRF TBC1D3K TBC1D3F VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.73e-06 | 213 | 213 | 12 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | PRTG TBC1D3G MYRF TBC1D3K TBC1D3F VWF TBC1D3 TBC1D3H TBC1D3L TBC1D3D IRX3 TBC1D3C TBC1D3B | 2.25e-05 | 320 | 213 | 13 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#3 | IRX5 MR1 F13A1 ADGRL3 CKMT1A DNAH2 RNF213 NBEA IRX3 MYH14 FILIP1L | 3.02e-05 | 238 | 213 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | IRX5 MR1 PTGFRN F13A1 OLFML2A OSBPL5 ADGRL3 TBCE TECPR1 CKMT1A DOC2B SYNE1 DNAH2 RNF213 NBEA IRX3 PIEZO2 MYH14 AKAP13 FILIP1L | 4.59e-05 | 726 | 213 | 20 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | F13A1 DST STXBP1 NYNRIN SYNE2 C3 DMXL2 VWF DEPTOR ITSN1 NBEA TFR2 TBC1D8 IRAK3 | 7.07e-05 | 409 | 213 | 14 | GSM476663_500 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | PRTG TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PABIR3 | 1.34e-04 | 281 | 213 | 11 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | PRTG TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PABIR3 | 1.34e-04 | 281 | 213 | 11 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ZNF184 CCDC18 MR1 F13A1 HNRNPU TMEM163 DMD ADGRL3 CKMT1A FAM149A DOC2B VWF ANK1 DNAH2 RNF213 DPYSL4 LRRC8D EIF4E1B GTF3A MYH14 BAZ1A MACF1 FILIP1L | 1.36e-04 | 978 | 213 | 23 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | APTX SPTBN2 MR1 ADGRV1 SYNE2 TMEM163 DMD ADGRL3 RASAL2 CKMT1A DOC2B VWF DNAH2 AP1M2 RNF213 DPYSL4 LRRC8D PDLIM1 MYH14 BAZ1A NINL MACF1 FILIP1L | 1.49e-04 | 984 | 213 | 23 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | TRPM4 SPTB PEX13 RYR1 NLGN3 CLCN5 NOS1 DMXL2 TBC1D3L ITSN1 LRRK1 TBC1D8 PIEZO2 FILIP1L | 1.44e-12 | 197 | 222 | 14 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | TRPM4 SPTB PEX13 RYR1 NLGN3 CLCN5 NOS1 DMXL2 TBC1D3L ITSN1 LRRK1 TBC1D8 PIEZO2 FILIP1L | 1.44e-12 | 197 | 222 | 14 | 15b87fd3906d7388c271d30d0c64b1bcc490801c |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 SPTA1 ADGRV1 CAPN8 FAT1 ADAMTS16 DMD ADGRL3 ANK1 PIEZO2 DNAH11 | 2.36e-09 | 184 | 222 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 SPTA1 ADGRV1 CAPN8 FAT1 ADAMTS16 DMD ADGRL3 ANK1 PIEZO2 DNAH11 | 2.36e-09 | 184 | 222 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 SPTA1 ADGRV1 CAPN8 FAT1 ADAMTS16 DMD ADGRL3 ANK1 PIEZO2 DNAH11 | 2.36e-09 | 184 | 222 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PTPRB DST STXBP1 UBR5 SYNE2 ADGRL3 DOC2B VWF SLF1 RNF213 MACF1 | 5.65e-09 | 200 | 222 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA13 FAT1 TMEM163 ADGRL3 OXR1 SYNE1 IRX3 SYT10 DNAH17 DNAH11 | 2.07e-08 | 176 | 222 | 10 | 327a3e81b724252e36d786de92a3ffd721ea6d7b |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-08 | 189 | 222 | 10 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-08 | 191 | 222 | 10 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-08 | 200 | 222 | 10 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 6.93e-08 | 200 | 222 | 10 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-08 | 200 | 222 | 10 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-07 | 177 | 222 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-07 | 183 | 222 | 9 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.64e-07 | 183 | 222 | 9 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-07 | 184 | 222 | 9 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.81e-07 | 184 | 222 | 9 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-07 | 185 | 222 | 9 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-Progenitor_Erythro-Mega|blood / Manually curated celltypes from each tissue | 4.18e-07 | 186 | 222 | 9 | 59c115bbbb4bca4ad80be1809d8a0422b8438ea3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.00e-07 | 190 | 222 | 9 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.22e-07 | 191 | 222 | 9 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.95e-07 | 194 | 222 | 9 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.95e-07 | 194 | 222 | 9 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 197 | 222 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 197 | 222 | 9 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 197 | 222 | 9 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 6.76e-07 | 197 | 222 | 9 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 197 | 222 | 9 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 6.76e-07 | 197 | 222 | 9 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-07 | 198 | 222 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 199 | 222 | 9 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 7.36e-07 | 199 | 222 | 9 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.36e-07 | 199 | 222 | 9 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 7.36e-07 | 199 | 222 | 9 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.36e-07 | 199 | 222 | 9 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 199 | 222 | 9 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 7.36e-07 | 199 | 222 | 9 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.36e-07 | 199 | 222 | 9 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 3.08e-06 | 177 | 222 | 8 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 182 | 222 | 8 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-06 | 182 | 222 | 8 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.95e-06 | 183 | 222 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 183 | 222 | 8 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 4.11e-06 | 184 | 222 | 8 | b81a2a95944cee8fec13d63dc0d95496e67aa937 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 184 | 222 | 8 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 186 | 222 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 134 | 222 | 7 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.01e-06 | 189 | 222 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-06 | 190 | 222 | 8 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-06 | 190 | 222 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-06 | 191 | 222 | 8 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.41e-06 | 191 | 222 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.41e-06 | 191 | 222 | 8 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-06 | 191 | 222 | 8 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.41e-06 | 191 | 222 | 8 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.41e-06 | 191 | 222 | 8 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.41e-06 | 191 | 222 | 8 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 5.62e-06 | 192 | 222 | 8 | cbc304c704e8524eee24a1619d0fbb2cf96c4976 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.62e-06 | 192 | 222 | 8 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.62e-06 | 192 | 222 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.84e-06 | 193 | 222 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.84e-06 | 193 | 222 | 8 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 193 | 222 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 193 | 222 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 193 | 222 | 8 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 194 | 222 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.07e-06 | 194 | 222 | 8 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.07e-06 | 194 | 222 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.07e-06 | 194 | 222 | 8 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-06 | 195 | 222 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 195 | 222 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 196 | 222 | 8 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.04e-06 | 198 | 222 | 8 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.04e-06 | 198 | 222 | 8 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.04e-06 | 198 | 222 | 8 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.04e-06 | 198 | 222 | 8 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.31e-06 | 199 | 222 | 8 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 7.58e-06 | 200 | 222 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.58e-06 | 200 | 222 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 7.58e-06 | 200 | 222 | 8 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 7.58e-06 | 200 | 222 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 164 | 222 | 7 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 164 | 222 | 7 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 164 | 222 | 7 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 112 | 222 | 6 | 456278fb92dd41820fde8cf27c68fec45e15f972 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 168 | 222 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-05 | 170 | 222 | 7 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 171 | 222 | 7 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 173 | 222 | 7 | 98e464d9e6d6b69421e9e4041b638b6825247f60 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-05 | 50 | 117 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | plakin | 6.39e-08 | 82 | 209 | 9 | CID000018752 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.73e-19 | 46 | 217 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 9.60e-17 | 69 | 217 | 14 | DOID:1682 (implicated_via_orthology) |
| Disease | hereditary spherocytosis (is_implicated_in) | 3.88e-06 | 5 | 217 | 3 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 3.88e-06 | 5 | 217 | 3 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 3.88e-06 | 5 | 217 | 3 | C0221409 | |
| Disease | Hereditary spherocytosis | 2.14e-05 | 8 | 217 | 3 | C0037889 | |
| Disease | PR interval | PCNX3 MYCBP2 ZNF184 FAT1 SYNE2 CAMTA1 ADGRL3 USP28 SUN1 MACF1 NUDCD1 CDC5L DNAH11 | 8.45e-05 | 495 | 217 | 13 | EFO_0004462 |
| Disease | cryptorchidism (implicated_via_orthology) | 1.61e-04 | 3 | 217 | 2 | DOID:11383 (implicated_via_orthology) | |
| Disease | breast angiosarcoma (is_implicated_in) | 1.61e-04 | 3 | 217 | 2 | DOID:4511 (is_implicated_in) | |
| Disease | Lung diseases | 2.80e-04 | 78 | 217 | 5 | C0024115 | |
| Disease | reticulocyte measurement | SPTA1 SPTB FAT1 PIK3CA SYNE2 VWF ANK1 DEPTOR OXR1 TRIM31 ARHGAP9 TFR2 TBC1D8 UBE2O BAZ1A DNAH17 LRP5 AKAP13 ACAP2 | 3.11e-04 | 1053 | 217 | 19 | EFO_0010700 |
| Disease | Hereditary elliptocytosis | 3.20e-04 | 4 | 217 | 2 | cv:C0013902 | |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 3.20e-04 | 4 | 217 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 3.20e-04 | 4 | 217 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.20e-04 | 4 | 217 | 2 | cv:CN293514 | |
| Disease | Global developmental delay | 4.66e-04 | 133 | 217 | 6 | C0557874 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.31e-04 | 5 | 217 | 2 | C1450051 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 5.31e-04 | 5 | 217 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 5.31e-04 | 5 | 217 | 2 | DOID:11723 (is_marker_for) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.31e-04 | 5 | 217 | 2 | C0410190 | |
| Disease | Familial Exudative Vitreoretinopathy | 5.31e-04 | 5 | 217 | 2 | C0339539 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.28e-04 | 195 | 217 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | neutrophil percentage of leukocytes | ZCWPW2 SPTA1 NCLN MED24 ERAP2 SLC25A24 ANK1 SH2D3C TBC1D8 UBE2O AKAP13 PRKDC XKR5 | 6.30e-04 | 610 | 217 | 13 | EFO_0007990 |
| Disease | reticulocyte count | EPRS1 SPTA1 SPTB FAT1 SYNE2 MYRF VWF ANK1 OXR1 TRIM31 ARHGAP9 TFR2 TBC1D8 UBE2O BAZ1A DNAH17 LRP5 ACAP2 | 7.67e-04 | 1045 | 217 | 18 | EFO_0007986 |
| Disease | Emery-Dreifuss muscular dystrophy | 7.92e-04 | 6 | 217 | 2 | cv:C0410189 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 7.92e-04 | 6 | 217 | 2 | EFO_0801920 | |
| Disease | Elliptocytosis, Hereditary | 7.92e-04 | 6 | 217 | 2 | C0013902 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.92e-04 | 6 | 217 | 2 | C0410189 | |
| Disease | red blood cell density measurement | WWOX SPTA1 ADGRV1 DST UBR5 PIK3CA CAMTA1 HSF2 MYRF ANK1 ITSN1 DNAH2 IRX1 TFR2 BAZ1A AKAP13 | 8.58e-04 | 880 | 217 | 16 | EFO_0007978 |
| Disease | Adenoid Cystic Carcinoma | 8.78e-04 | 100 | 217 | 5 | C0010606 | |
| Disease | revision of total knee arthroplasty | 9.00e-04 | 26 | 217 | 3 | EFO_0020972 | |
| Disease | Cerebellar Diseases | 1.10e-03 | 7 | 217 | 2 | C0007760 | |
| Disease | osteopetrosis (implicated_via_orthology) | 1.10e-03 | 7 | 217 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.10e-03 | 7 | 217 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.10e-03 | 7 | 217 | 2 | C0751337 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 1.46e-03 | 8 | 217 | 2 | C0796250 | |
| Disease | manic episode measurement, depressive episode measurement | 1.87e-03 | 9 | 217 | 2 | EFO_0007704, EFO_0007705 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.30e-03 | 75 | 217 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.34e-03 | 36 | 217 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 2.34e-03 | 36 | 217 | 3 | cv:C0008780 | |
| Disease | Developmental delay (disorder) | 2.53e-03 | 37 | 217 | 3 | C0424605 | |
| Disease | Malignant neoplasm of breast | WWOX LRRC37A2 PKDREJ SYNJ2 PIK3CA SYNE2 NFYC AP1M1 DMD RASAL2 VWF ANK1 SYNE1 OCA2 MACF1 TEKT4 KLHDC10 | 2.61e-03 | 1074 | 217 | 17 | C0006142 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.61e-03 | 128 | 217 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.61e-03 | 128 | 217 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.61e-03 | 128 | 217 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.61e-03 | 128 | 217 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.61e-03 | 128 | 217 | 5 | C0007134 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.83e-03 | 11 | 217 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | guanosine diphosphate measurement | 2.83e-03 | 11 | 217 | 2 | EFO_0010494 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.83e-03 | 11 | 217 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Ischemic stroke | 2.87e-03 | 324 | 217 | 8 | HP_0002140 | |
| Disease | factor VIII measurement | 3.17e-03 | 40 | 217 | 3 | EFO_0004630 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.22e-03 | 194 | 217 | 6 | EFO_0004265, EFO_0007908 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.38e-03 | 12 | 217 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Abruptio Placentae | 3.38e-03 | 12 | 217 | 2 | EFO_1001754 | |
| Disease | Congenital muscular dystrophy | 3.38e-03 | 12 | 217 | 2 | cv:C0699743 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 3.65e-03 | 42 | 217 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 3.98e-03 | 13 | 217 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 3.98e-03 | 13 | 217 | 2 | C0751198 | |
| Disease | Fetal Alcohol Spectrum Disorders | 3.98e-03 | 13 | 217 | 2 | C2985290 | |
| Disease | Hepatic Encephalopathy | 3.98e-03 | 13 | 217 | 2 | C0019151 | |
| Disease | Hepatic Coma | 3.98e-03 | 13 | 217 | 2 | C0019147 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.33e-03 | 144 | 217 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.62e-03 | 14 | 217 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | early cardiac repolarization measurement | 4.62e-03 | 14 | 217 | 2 | EFO_0004885 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.86e-03 | 148 | 217 | 5 | C0279702 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 5.01e-03 | 47 | 217 | 3 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | Primary Ciliary Dyskinesia | 5.01e-03 | 47 | 217 | 3 | C4551720 | |
| Disease | cleft lip | 5.23e-03 | 284 | 217 | 7 | EFO_0003959 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.43e-03 | 152 | 217 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | forced expiratory volume | ILF3 WWOX SPTBN2 ZNF184 KIAA0753 DST ANK1 SYNE1 TASP1 ARHGAP12 SMARCA2 LRP5 CDC5L | 5.88e-03 | 789 | 217 | 13 | EFO_0004314 |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 6.04e-03 | 16 | 217 | 2 | C0393706 | |
| Disease | Benign neoplasm of stomach | 6.81e-03 | 17 | 217 | 2 | C0153943 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 6.81e-03 | 17 | 217 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.81e-03 | 17 | 217 | 2 | C0496905 | |
| Disease | muscular dystrophy (is_implicated_in) | 6.81e-03 | 17 | 217 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Carcinoma in situ of stomach | 6.81e-03 | 17 | 217 | 2 | C0154060 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 6.81e-03 | 17 | 217 | 2 | OBA_2045173 | |
| Disease | Fetal Alcohol Syndrome | 6.81e-03 | 17 | 217 | 2 | C0015923 | |
| Disease | interleukin 1 receptor antagonist measurement | 7.01e-03 | 53 | 217 | 3 | EFO_0004754 | |
| Disease | epilepsy (implicated_via_orthology) | 7.25e-03 | 163 | 217 | 5 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TAWAHVAVRLIKDSV | 501 | Q99424 | |
| TEWSREEEEKLLHLA | 61 | Q99459 | |
| KWRTKHADSIDLELE | 1086 | Q9Y6Y1 | |
| RHLKAWDDNLTLDIS | 401 | Q9NX77 | |
| DTRKWTLVGHELLNT | 91 | Q9Y614 | |
| EEIRLDTSSEASHWK | 796 | Q6P2P2 | |
| LIWIESVIEKFSHSR | 276 | Q9Y6Q5 | |
| WLRAEVKRLSHELAE | 21 | Q8TD16 | |
| LVVLRSENGSVWKEH | 1006 | P16157 | |
| HTGDTESQVRLLWKD | 656 | P49747 | |
| VWDIILSSHRSNFKD | 471 | Q7Z2Y8 | |
| LHISSDASRLAIIWK | 146 | Q9UNA3 | |
| VEVHASSKEERNSWI | 2311 | Q12802 | |
| SDAVHDLLLDVITWV | 856 | Q9HAR2 | |
| RLEWTIDEKAKHNLS | 4071 | Q8WXG9 | |
| WTSISSLKAVAREHL | 221 | Q7Z2E3 | |
| KRWHIDTILHVLTTA | 416 | O75843 | |
| LIWIESVIEKHSHSR | 276 | Q9BXS5 | |
| IHWESASLLRSEETK | 1311 | P01024 | |
| RWETTKKIAATVRHE | 1221 | Q96DT5 | |
| VQLISEDWSLEKSTH | 2006 | Q86UQ4 | |
| DSLSSEEVHKWNLVL | 346 | A6NHC0 | |
| VSEHRKDLGLTTVWE | 536 | Q8TAP6 | |
| LDWVSKEDGSHILTV | 1171 | Q8TDJ6 | |
| ILREHIAKAEAEVWA | 66 | Q5TEZ5 | |
| LSSGETEELQRIKWH | 11 | Q9UIA0 | |
| RKRLDVDITELHSWI | 721 | P11532 | |
| VDITELHSWITRSEA | 726 | P11532 | |
| IRSHLEASSDQWKRL | 2796 | P11532 | |
| TEIKEQRHWDISSSE | 531 | Q96G46 | |
| VHFSKVRSLTLDTWE | 446 | Q15057 | |
| RLWELSVTQEHIFSK | 1361 | Q96PN6 | |
| LRVFTEKHSESWELD | 536 | Q9UMQ6 | |
| QEETWRLSFSHIEKE | 371 | Q8N884 | |
| VTDKFHIDWDSVLID | 576 | Q8N608 | |
| ASEVLVTSRTWELAH | 216 | Q8TE57 | |
| LHLSTLDRSVIWSKS | 1131 | Q9NRL2 | |
| WLEESAHKDSDALTL | 146 | Q9UFE4 | |
| VSWRLLSVEHEDFLT | 341 | Q8NDN9 | |
| LTHVVEWIDFETLAL | 376 | Q04671 | |
| NETEILIWKSHVSGE | 91 | Q96IZ5 | |
| RETTSTLKAWLQEHR | 151 | P78413 | |
| TRDATATLKAWLNEH | 121 | P78411 | |
| PRIELSVWKDDLTTH | 116 | Q8IXQ6 | |
| SVWKDDLTTHAVDAV | 121 | Q8IXQ6 | |
| DVLVKGDSRWVTTLH | 121 | Q6DT37 | |
| KRWLEDNLDHTDSSL | 286 | Q969V3 | |
| HESSTWIIKESNSLE | 331 | Q96RS6 | |
| WVKVESTDVSDLLHQ | 256 | P28062 | |
| SEIQISHSWEEGLKL | 101 | Q6P4D5 | |
| HSVWTLRRVKSEEEN | 266 | Q9H1A4 | |
| TGWITTLKELDHEKR | 2866 | Q14517 | |
| QWSHISESAKDLVRR | 241 | O14936 | |
| KESRVLAPWITETHF | 331 | P23467 | |
| LKVDTSESLWHIQIS | 146 | Q14667 | |
| RWKDLTHAISILESA | 1271 | O60309 | |
| LLEKHVSSLRAHETW | 2411 | Q9NU22 | |
| KSSALLHDLREIEAW | 236 | Q8WXG6 | |
| RWKDLTHAISILESA | 1271 | A6NM11 | |
| LTTETGLQKDHALWD | 236 | O76036 | |
| VELLEELIRKHWETT | 466 | A5PLN7 | |
| ELIRKHWETTLTEGK | 471 | A5PLN7 | |
| AWSRKHKTLSIDQDE | 136 | Q5VYY2 | |
| VVHGEATIRTTKWEL | 666 | Q38SD2 | |
| DSITTIKHWITIIRA | 6996 | Q03001 | |
| HLVTKVDTVEDFWAL | 86 | A6NMX2 | |
| TDWNLHSIERADKTS | 861 | O75197 | |
| TAADHQTILRAWAVK | 446 | Q5JUK3 | |
| DEAWSTLLRTVHSIL | 201 | Q8N3T1 | |
| RIKWASHVLTREELE | 111 | Q9UL16 | |
| LATSEATWKDTEHSR | 536 | Q5VYM1 | |
| LHQSTDRLTAEIWKD | 626 | Q7Z406 | |
| KLEVWLSHEGITAAL | 1501 | Q9H6A9 | |
| STDLHKLDLNTREWT | 231 | Q6PID8 | |
| TKDIDIHEVRIGWSL | 351 | Q00839 | |
| LRTSHWEEAIQETKG | 71 | Q8TBE9 | |
| RELSVLHSLLWEVVS | 571 | Q9UJF2 | |
| LNVTSVHLFKERWDT | 46 | P00488 | |
| ELWTRSHRDDSEKLL | 641 | Q3SXY7 | |
| ERLSSSWLDVRHIEK | 46 | Q9Y616 | |
| SSAISKHWEAELATL | 176 | Q86YM7 | |
| FITELTLRAWIHTED | 76 | Q13952 | |
| SEITEQEKDFLWSHR | 541 | P42336 | |
| SLHKFVSRATAELIW | 681 | Q9UPN3 | |
| VLTKWRHSTIVLDTN | 416 | Q8IWW6 | |
| SRVDWLELNETGHKL | 486 | Q9UG01 | |
| WETEVVLTDTLHLKS | 311 | P29475 | |
| ISWSRLDHKSIDVFN | 266 | Q2VWP7 | |
| DVWKTILSEVRFVHV | 456 | Q9Y6A1 | |
| SQTEAEELRKLWKTH | 496 | Q8N573 | |
| RKTLVALFTDHQWVE | 471 | Q9NZ94 | |
| AEWRSTFHKDVVVDL | 491 | Q02218 | |
| SLHVDITRWHESIKE | 136 | O14531 | |
| ITRWHESIKEELEAL | 141 | O14531 | |
| SKEEKEDWLSHALSR | 416 | Q8TES7 | |
| KDKRIERWHTLTSEL | 391 | Q14184 | |
| WVLLSRHITDKDDFA | 586 | Q9Y6W3 | |
| WLSVEDILAVRAVHS | 46 | P41002 | |
| TIIDWSHQIRDVLSK | 196 | Q9UFH2 | |
| NVASLRHELKITEWS | 21 | Q5T9S5 | |
| RHELKITEWSLQSLG | 26 | Q5T9S5 | |
| EWSVTKRQVILLHTE | 181 | Q8WVC6 | |
| EKTETSHEQWLFKRL | 691 | Q4L180 | |
| EAWSTLLRTIHSVLE | 146 | Q8N4A0 | |
| SLDIWAITVEERAKH | 11 | Q15811 | |
| KEWVSALIHSELAEI | 211 | Q53FE4 | |
| DRHREITNKSKESTW | 101 | P51795 | |
| DWLIEHKEASDRETA | 71 | Q8TB45 | |
| ETTETTEVIKRLWVH | 2196 | Q8WXX0 | |
| EKTRWSHTALELGQL | 2886 | Q8WXX0 | |
| SHTERALKAVSDWID | 36 | Q12906 | |
| LEITEKRHGTLVWDT | 416 | Q9Y2G2 | |
| WDALSQTKAALRHIE | 31 | Q5VT06 | |
| SELTLSQKHWLSDRT | 176 | P01854 | |
| SSASDKLWVTRVIAH | 356 | Q6P179 | |
| DLSKIEIHRVWTSAS | 2306 | Q5TBA9 | |
| HDITDWVVGTRVKSA | 366 | Q86Y56 | |
| KDFHDTKSSITRLWI | 2631 | Q9P225 | |
| DWEHSIALRNISLAK | 291 | Q6ZMJ2 | |
| VTSEEELHLTRKLFW | 2666 | P21817 | |
| KSFLIWVNEEDHTRV | 256 | P12532 | |
| AVERHESLTSWNLAK | 131 | Q5T6X4 | |
| LREISLNHEWTFEKL | 446 | Q7L1W4 | |
| GDLSVHRETTWKTRL | 556 | Q68BL7 | |
| ELLELHWRVADKASE | 1796 | Q9P2P1 | |
| NLTLTVARSEHKVWS | 76 | O00151 | |
| KDTLSWLAVDNVAHT | 146 | Q95460 | |
| LSKLWTLVEETHTNE | 11 | Q03933 | |
| RESTSTLKAWLNEHR | 136 | P78415 | |
| DKTFLIWINEEDHTR | 256 | P17540 | |
| ESERLWQHVTRAISK | 646 | Q9H0X9 | |
| DHTSEKSWDSRIDLI | 346 | Q99567 | |
| VLADSVHLAWDLSRS | 86 | O43482 | |
| IIKHSDDEVSATASW | 1216 | Q9H1H9 | |
| DWKSDLSLERVSVLE | 761 | Q9P2B2 | |
| SERLLDLHQSWKTKD | 351 | P53609 | |
| SEELHAALSEWLTAI | 401 | Q9BZY9 | |
| TEIDHWLEFSATKLS | 76 | P07814 | |
| VEHLIEKWELQRSLS | 61 | Q9H7E2 | |
| LSKAVATWHANTERE | 476 | P51531 | |
| IEAELRSTKHWELTA | 51 | Q9Y285 | |
| RSTKHWELTAEGEEI | 56 | Q9Y285 | |
| NRLEVTWDDTKRLIH | 2061 | Q8NF91 | |
| SLRTWLAHIESELAK | 7896 | Q8NF91 | |
| SRESVELLLEDWHKF | 511 | Q8WXH0 | |
| TLGHWVTISDQEKRT | 1471 | O15056 | |
| KWTVDDVHSFIRSLP | 326 | Q7Z3H4 | |
| RESTSTLKAWLNEHR | 136 | P78414 | |
| KWLSVDTTLDRTFHV | 1331 | Q9NTG1 | |
| TVRHLKANSAVVSWD | 41 | Q8NAU1 | |
| RVWVDTLSIAHSKVT | 936 | Q8NFP9 | |
| LSIDSVEDHLAWSKD | 71 | P30041 | |
| AKLEEASSWTAIEHS | 181 | O75448 | |
| VGERLQDTHSWKSEL | 91 | Q8WW24 | |
| IKQVDLDSRHIGWVT | 3826 | O75592 | |
| ATRVREEWEHAISSK | 3981 | O75592 | |
| HLSEAWSRVTKNAIA | 4186 | O75592 | |
| WKLLSTHSDEVTDSI | 251 | Q92968 | |
| HEAARLAWLDAETSK | 606 | Q2KHM9 | |
| AVAAEKWSHLSLTRR | 226 | Q96JS3 | |
| TWARDEDTVLKHLRA | 331 | B9A6J9 | |
| LKSHLWRSASLESVE | 136 | Q9Y2I6 | |
| DLWIALRHKHIAEVS | 286 | P61764 | |
| LANATLTWEHEASRK | 436 | Q96J65 | |
| SSWLIEDGKVVTVHL | 231 | Q9Y266 | |
| SLKWETERARQVLEH | 201 | Q96H20 | |
| KLIHTLDDRTQLWAS | 526 | Q9BXP5 | |
| LQSWKHLEDGARTET | 311 | Q9BWW9 | |
| LHSKLIVSENSREGW | 191 | Q53FZ2 | |
| LDATVHEDKIILTWT | 761 | Q14CN2 | |
| TWARDEDTVLKHLRA | 331 | A6NDS4 | |
| TWARDEDTVLKHLRA | 331 | P0C7X1 | |
| LEWLKTVNESHGSVE | 1516 | Q63HN8 | |
| ERATQESTLDHWKFL | 426 | A6NCW0 | |
| EQLAKWIADRTDVHI | 176 | Q13454 | |
| SVVWDRHLSISVVLK | 971 | P04275 | |
| VVSVSRDGTLKVWDH | 2161 | Q99973 | |
| LHRRWDELETTTQAK | 1361 | O15020 | |
| SKNLLSSWDEVIHIA | 161 | Q15813 | |
| TWARDEDTVLKHLRA | 331 | A6NER0 | |
| WTLVDVRRDLHKTTI | 281 | A6NE52 | |
| HSIALWAVSDKGDVL | 951 | Q7Z6L1 | |
| AAERDWTVSLEHILA | 1076 | O95759 | |
| ERATQESTLDHWKFL | 426 | D6R9N7 | |
| ETSDLRNKWHLVIDR | 901 | Q9H5I5 | |
| RIESWLETHALLEKA | 1141 | Q9C0C9 | |
| ERATQESTLDHWKFL | 426 | A8MUK1 | |
| IHVWDIESKEQVRTL | 581 | Q6Q0C0 | |
| ERATQESTLDHWKFL | 426 | D6R901 | |
| ASEAVSRILEEWHKA | 161 | Q9NZC7 | |
| ERATQESTLDHWKFL | 426 | D6RCP7 | |
| STEWDDIHVVTGALK | 621 | Q9BRR9 | |
| LETIDSLQKHSWVAD | 286 | O14492 | |
| TWARDEDTVLKHLRA | 331 | A0A087X179 | |
| ALHRLWDELQATTKE | 1356 | P11277 | |
| EDLVSSWEHIRALAT | 346 | P02549 | |
| VLERTWKHLSDIIEE | 2126 | P02549 | |
| ERATQESTLDHWKFL | 426 | Q7RTZ2 | |
| VSEFTHKLLDWLEDA | 256 | Q96RU2 | |
| VSDLSREATVWKDIH | 341 | Q6XYQ8 | |
| HKETTSVHTDWLLDL | 996 | Q9BQI6 | |
| WSESSEHLQLVVTDK | 106 | Q6UX27 | |
| ELHKESKTRDDWLVS | 3261 | P78527 | |
| LASSKTHEITQLESW | 56 | Q6PK81 | |
| IWKVDHVLERLQSES | 81 | Q9GZX5 | |
| ERATQESTLDHWKFL | 426 | C9JPN9 | |
| HLFVLIQKSWETESD | 511 | Q9UPU5 | |
| TTSGKVLDVLWELAH | 546 | Q9UPU5 | |
| ERATQESTLDHWKFL | 426 | Q0WX57 | |
| ETSNSEDRLLKHWVS | 36 | Q96JF6 | |
| EELKLSSTDLRSHAW | 206 | Q8N5H7 | |
| TWTELLKHVRETHKE | 201 | Q92664 | |
| TWARDEDTVLKHLRA | 331 | A0A087WVF3 | |
| ELDQLKSELSSWRHV | 481 | O94901 | |
| WRLLSSEDSAKVDHD | 41 | Q504Y3 | |
| VSSSHDKSLRLWERT | 691 | Q9UNX4 | |
| RHWDAALTSLQKELE | 81 | Q6UX68 | |
| TTHSRAARAIQEWLK | 406 | Q3LXA3 | |
| ERATQESTLDHWKFL | 426 | D6RA61 | |
| TWARDEDTVLKHLRA | 331 | Q6DHY5 | |
| TWARDEDTVLKHLRA | 331 | Q8IZP1 | |
| ERATQESTLDHWKFL | 426 | C9J2P7 | |
| ERATQESTLDHWKFL | 426 | D6RBQ6 | |
| ILLSAEVFKHDSAVW | 236 | Q8TC26 | |
| KQTLLVEFLWSHTTE | 361 | Q9H6P5 | |
| AALSRQKLDHVWTDT | 181 | Q9UP52 | |
| VTDIEEIIRFWKHST | 156 | Q6NUK1 | |
| TWARDEDTVLKHLRA | 331 | A0A087X1G2 | |
| EAERKLLTWESVHKE | 1116 | Q8TD43 | |
| ESLISAHDILSWIKQ | 356 | Q9UDV7 | |
| SHTSIWLLRTDFVLE | 246 | Q9HAW7 | |
| EVTSKLFDEIHWIIV | 276 | O95922 | |
| TWARDEDTVLKHLRA | 331 | A0A087WXS9 | |
| TWARDEDTVLKHLRA | 331 | Q6IPX1 | |
| ERATQESTLDHWKFL | 426 | D6RJB6 | |
| IVEKHKRDDSWSSNL | 126 | Q99676 | |
| IAREWSEKAAHLLAL | 476 | C9JLR9 | |
| WVDETLSSVASKLEH | 446 | O95071 | |
| ERATQESTLDHWKFL | 426 | C9JJH3 | |
| ERATQESTLDHWKFL | 426 | C9JVI0 | |
| SSHLEQREALWIEEK | 126 | Q86TJ5 | |
| LELQVLTAHSWREKA | 1071 | P41229 | |
| NLETRIDELERWSHK | 691 | Q9Y2G1 | |
| ADASHVSWRLLDVVT | 186 | Q14957 |